Ladies of Liberty: Dr. Rima Laibow


Several operations have been taking place under the guise of oversimplified statist narratives and their portrayal to us by amoral multinational corporations. In one such case, Dr. Rima Laibow was moved to the front of the Justice Department’s hit list, as she was publicly empowering people with vital informational resources deemed as misinformation by big government. In the face of an overt vaccine monopoly being cultivated by big government, big media, big tech, big business and big medicine, Dr. Rima Laibow was one of the first casualties taking place in the secret narrative war surrounding the most recent chapter in the manufactured human experience.



Governments of the world have had their hands full managing the multidisciplinary approach to recent viral episodes. In one of the most publicly visible contentions, the American government quickly went to work against a horse dewormer being utilized to fight recent outbreaks. In this article from MSNBC, the American Medical Association forced doctors to stop prescribing Ivermectin, a medication described solely as a horse dewormer by liberal media outlets, in yet another low-information oversimplification.

At the University of Connecticut, in the publication entitled, “Ivermectin is a Nobel Prize-Winning Wonder Drug — But Not for COVID-19”, the authors recognize Ivermectin as follows: “Ivermectin is an over 30-year-old wonder drug that treats life- and sight-threatening parasitic infections. Its lasting influence on global health has been so profound that two of the key researchers in its discovery and development won the Nobel Prize in 2015.”

As we can see here, the government generated narrative stipulates that Ivermectin cannot be used against recent outbreaks, indicating that any opinions to the contrary would be labeled as misinformation.

In the Japanese Journal of Antibiotics, a paper entitled “Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen” states the following:

Several studies reported antiviral effects of ivermectin on RNA viruses such as Zika, dengue, yellow fever, West Nile, Hendra, Newcastle, Venezuelan equine encephalitis, chikungunya, Semliki Forest, Sindbis, Avian influenza A, Porcine Reproductive and Respiratory Syndrome, Human immunodeficiency virus type 1, and severe acute respiratory syndrome coronavirus 2. Furthermore, there are some studies showing antiviral effects of ivermectin against DNA viruses such as Equine herpes type 1, BK polyomavirus, pseudorabies, porcine circovirus 2, and bovine herpesvirus 1. Ivermectin plays a role in several biological mechanisms, therefore it could serve as a potential candidate in the treatment of a wide range of viruses including COVID-19 as well as other types of positive-sense single-stranded RNA viruses.

In an article from the Western Journal, Tokyo’s Medical Association Chairman Dr. Haruo Ozaki holds a live press conference regarding the beneficial usage of Ivermectin.

In another such discussion, Dr. Kazuhiro Nagao, director of the Nagao Clinic and a university professor, appears on Japanese TV saying he’s used ivermectin as early treatment for over 500 covid patients with practically 100% success rate. He asks for nationwide use.

In a scientific publication from The Indian Journal of Tuberculosis entitled “White paper on Ivermectin as a potential therapy for COVID-19”, it states:

A group of senior doctors with vast clinical experience met on 19th July’20 under the aegis of Academy of Advanced Medical Education. The panel looked at Ivermectin, one of the old molecule and evaluated it’s use in COVID 19 (Novel Coronavirus Disease 2019) management. After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with Coronavirus, owing to its anti-viral properties coupled with effective cost, availability and good tolerability and safety.

In the American Journal of Therapeutics, yet another medical and scientific peer reviewed journal, in the publication entitled “Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” it states:

Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.

The United States government has a recent history of blatantly favoring vaccine monopolies despite overwhelming evidences of multidisciplinary approaches at treating modern illness.

In a publication from Forbes magazine entitled, “U.S. Limits Covid Antibody Treatments For All States As Shortage Fears Rise”, it states:

After moving to limit supplies for a handful of states earlier this month, the Biden administration is further tightening its grip on states’ access to monoclonal antibodies following a dramatic surge in demand for the life-saving treatments in states with high coronavirus cases and low vaccination rates — despite the president just last week vowing to ramp up distribution of the drugs.

The FDA even prevented treatments with monoclonal antibodies based on pigeon holed data concerning the merry-go-round of variants popping up all over the country, in an obvious attempt at facilitating the vaccine monopoly and yet ever more reliance on medical oversimplifications.

As we can see in the above evidences, the American government has a history and pathology of targeting proven viral therapies that are not involved in the unprecedented vaccine profits market from Pfizer, Moderna and J&J.

Enter, stage left, Dr. Rima Laibow, and her specialized approach at treating modern infections.




In an article from NEWSWEEK entitled “Justice Department Sue to Halt Sale of ‘Nano Silver’ Product That Claims to Cure, Prevent Coronavirus” it states

The DOJ filed a civil complaint for permanent injunction in the U.S. District Court for the District of New Jersey, naming Natural Solutions Foundation (NSF), Dr. Rima Laibow and Ralph Fucetola as defendants. A successful permanent injunction in this case would act as a court order blocking the company from continuing to sell its product.

Now let us examine the role of colloidal silver in modern medicinal applications to verify the veracity of the American Department of Justice claim against Dr. Rima Laibow.

In the publication entitled, “The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action” from the scientific peer reviewed journal Nanomaterials, it states:

AgNPs (Silver nanoparticles) are very important because of their unique physicochemical and antimicrobial properties, with a myriad of activities that are applicable in various fields, including wound care management. This review aimed to elucidate the underlying mechanisms of AgNPs that are responsible for their antiviral properties and their antibacterial activity towards the microorganisms.

In a scientific publication entitled “Antimicrobial peptides: A plausible approach for COVID-19 treatment” from the scientific journal Expert Opinions On Drug Discovery, it stipulates that antimicrobial agents will form a strong treatment basis against modern viral infections.

In an article entitled “Potent antiviral effect of silver nanoparticles on SARS-CoV-2” from the scientific medical journal Biochemical and Biophysical Research Communications, it states:

The pandemic of COVID-19 is spreading unchecked due to the lack of effective antiviral measures. Silver nanoparticles (AgNP) have been studied to possess antiviral properties and are presumed to inhibit SARS-CoV-2. Due to the need for an effective agent against SARS-CoV-2, we evaluated the antiviral effect of AgNPs. We evaluated a plethora of AgNPs of different sizes and concentration and observed that particles of diameter around 10 nm were effective in inhibiting extracellular SARS-CoV-2 at concentrations ranging between 1 and 10 ppm while cytotoxic effect was observed at concentrations of 20 ppm and above.

Now, from the American National Library of Medicine, in the journal of the United States Government Clinical Trials, we see the publication entitled, “Colloidal Silver, Treatment of COVID-19

When we look closely, we see that this study on Colloidal Silver and Covid19 was entered into the medical journal of American Clinical Trials in November of 2020, at the exact same time the Department of Justice ruthlessly attacked Dr. Rima Laibow, and prevented her from treating life threatening viral infection in patients, as publicized by NEWSWEEK magazine.

Once again, we have come full circle in yet another trying and acrobatic mental exercise worthy of a place in our history books. By the thorough examination of information and misinformation, we can see plainly that it is actually the government and media apparatus participating in misinformation by attempting to suppress legitimate scientific discoveries in favor of corporate monopolies.

In my most recent addition to the Ladies of Liberty series, in which we examine the strength and aptitude of the world’s foremost female scientists, we are humbled by the tenacity of Dr. Rima Laibow, and her commitment to the health and happiness of all people. In this series, it is my goal to document the trials and tribulations of expert women scientists, who have been routinely suppressed by the world’s biggest governments and corporations, in a desperate attempt to illuminate the minds of our people about the true nature of medical monopolies and how they are secretly facilitated by criminal governments.

18 views0 comments

Recent Posts

See All